Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DARATUMUMAB for Nephrotic syndrome: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 63 adverse event reports in the FDA FAERS database where DARATUMUMAB was used for Nephrotic syndrome.

Most Reported Side Effects for DARATUMUMAB

Side Effect Reports % Deaths Hosp.
Plasma cell myeloma 2,980 10.9% 680 439
Infusion related reaction 2,557 9.3% 241 629
Off label use 2,494 9.1% 425 783
Pneumonia 1,450 5.3% 336 1,018
Neutropenia 1,351 4.9% 192 371
Drug ineffective 1,110 4.1% 240 217
Thrombocytopenia 1,089 4.0% 199 374
Death 1,088 4.0% 1,088 200
Pyrexia 1,032 3.8% 140 592
Dyspnoea 996 3.6% 98 404
Neuropathy peripheral 955 3.5% 45 116
Anaemia 925 3.4% 171 380
Diarrhoea 916 3.3% 130 414
Fatigue 796 2.9% 73 207
Intentional product use issue 711 2.6% 56 108

Other Indications for DARATUMUMAB

Plasma cell myeloma (19,119) Product used for unknown indication (4,960) Plasma cell myeloma refractory (789) Primary amyloidosis (609) Amyloidosis (417) Plasma cell leukaemia (192) Plasma cell myeloma recurrent (131) Plasmablastic lymphoma (79) Plasmacytoma (79) Poems syndrome (62)

Other Drugs Used for Nephrotic syndrome

CORTICOTROPIN (1,254) RITUXIMAB (1,135) CYCLOSPORINE (721) MYCOPHENOLATE MOFETIL (623) PREDNISOLONE (538) TACROLIMUS (535) PREDNISONE (494) METHYLPREDNISOLONE (490) CYCLOPHOSPHAMIDE (220) OBINUTUZUMAB (125)

Related Pages

DARATUMUMAB Full Profile All Nephrotic syndrome Drugs DARATUMUMAB Demographics DARATUMUMAB Timeline